Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo

Blood

Volumn 92, Issue 11, 1998, Pages 4150-4166

  Gabrilovich, Dmitry ^a   Ishida, Tadao ^b   Oyama, Tsunehiro ^b   Ran, Sophia ^b   Kravtsov, Vladimir ^b   Nadaf, Sorena ^b   Carbone, David P ^b  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; RECOMBINANT VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; BURST FORMING UNIT E; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; COLONY FORMING UNIT E; COLONY FORMING UNIT GEMM; COLONY FORMING UNIT GM; CONTROLLED STUDY; DENDRITIC CELL; ENDOTHELIUM CELL; FEMALE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; IN VIVO STUDY; LYMPH NODE CELL; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; SPLEEN;

EID: 0032400862     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.11.4150     Document Type: Article

References (61)

1. Schuler G, Steinman RM: Dendritic cells as adjuvants for immune-mediated resistance to tumors. J Exp Med 186:1183, 1997
2. Gabrilovich D, Ciernik F, Carbone DP: Dendritic cells in antitumor immune responses. I. Detective antigen presentation in tumorbearing hosts. Cell Immunol 170:101, 1996
3. Chaux P, Moutet M, Faivre J, Martin F, Martin M: Inflammatory cells infiltrating human colorectal carcinomas express HLA class II but not B7-1 and B7-2 costimulatory molecules of the T-cell activation. Lab Invest 74:975, 1996
4. Chaux P, Favre N, Martin M, Martin F: Tumor-infiltrating dendritic cells are defective in their antigen-presenting function and inducible B7 expression in rats. Int J Cancer 72:619, 1997
5. Gabrilovich DI, Corak J, Ciernik IF, Kavanaugh D, Carbone DP: Decreased antigen presentation by dendritic cells in patients with breast cancer. Clin Cancer Res 3:483, 1997
6. Nestle FO, Burg G, Fah J, Wrone-Smith T, Nickoloff BJ: Human sunlight-induced basal-cell-carcinoma-associated dendritic cells are deficient in T cell co-stimulatory molecules and are impaired as antigen-presenting cells. Am J Pathol 150:641, 1997
7. Gabrilovich DI, Nadaf S, Corak J, Berzofsky JA, Carbone DP: Dendritic cells in anti-tumor immune responses. II. Dendritic cells grown from BM precursors, but not mature DC tram tumor-bearing mice are effective antigen carriers in the therapy of established tumors. Cell Immunol 170:111, 1996
8. Gabrilovich DI, Chen HL, Girgis KR, Cunningham HT, Meny GM, Nadaf S, Kavanaugh D, Carbone DP: Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat Med 2:1096, 1996
9. Steinbrink K, Wolfl M, Jonuleit H, Knop J, Enk AH: Induction of tolerance by IL-10-treated dendritic cells. J Immunol 159:4772, 1997
10. Menetrier-Caux C, Caux C, Dieu MC, Bain C, Iacono I, Favrot MC, Blay JY: IL-6 and M-CSF mediated inhibition of dendritic cell maturation by tumor cells, Proc Am Assoc Cancer Res 39:653, 1998
11. Jasani B, Navabi H, Adams M, Evans A, Mason M: Serum dependent downregulation of CD1a expression and specific CTL priming activity in human dendritic cells. Proc Am Assoc Cancer Res 30:611, 1998
12. Toi M, Taniguchi T, Yamamoto Y, Kurisaki T, Suzuki H, Tominaga T: Clinical significance of the determination of angiogenic factors [review]. Eur J Cancer 32A:2513, 1996
13. Ellis LM, Fidler IJ: Angiogenesis and metastasis. Eur J Cancer 32A:2451, 1996
14. Ferrara N, Smyth DT: The biology of vascular endothelial growth factor. Endocr Rev 18:4, 1997
15. Oyama T, Ran S, Ishida T, Nadaf S, Kerr L, Carbone D, Gabrilovich DI: Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kB activation in hematopoietic progenitor cells. J Immunol 160:1224, 1998
16. + cytotoxic T-cells. Cancer Res 53: 3257, 1993
17. Montesano R, Pepper MS, Mohle-Steinlein U, Risau W, Wagner EF, Orci L: Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene. Cell 62:435, 1990
18. RayChaudhury A, Frazier WA, D'Amore PA: Comparison of normal and tumorigenic endothelial cells: Differences in thrombospondin production and responses to transforming growth factor-beta. J Cell Sci 107(Pt 1):39, 1994
19. Baker KW, Habowsky JEJ: EDTA separation and ATPase Langerhans cell staining in the mouse epidermis. J Invest Dermatol 80:104, 1983
20. Muller HK, Halliday GM, Knight B: Carcinogen induced depletion of cutaneous Langerhans cells. Br J Cancer 52:81, 1985
21. Gabrilovich DI, Woods GM, Patterson S, Harvey JJ, Knight SC: Retrovirus-induced immunosuppression via blocking of dendritic cell migration and down-regulation of adhesion molecules. Immunology 82:82, 1994
22. Lord BI: in Testa NG, Molineux G (eds): Haemopoiesis: A Practical Approach. Oxford, UK, IRL Press, 1993, p 1
23. Vaddi K, Newton RC: Regulation of monocyte integrin expression by b-family chemokines. J Immunol 153:4721, 1994
24. Xia Y, Pauza ME, Feng L, Lo D: RelB regulation of chemokine expression modulates local inflammation. Am J Pathol 151:375, 1997
25. Osborn L, Kunkel S, Nabel GJ: Tumor necrosis factor and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kB. Proc Natl Acad Sci USA 86:2336, 1989
26. Takano S, Yoshii Y, Kondo S, Suzuki H, Maruno T, Shirai S, Nose T: Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients. Cancer Res 56:2185, 1996
27. Kondo S, Asano M, Matsuo K, Ohmori I, Suzuki H: Vascular endothelial growth factor/vascular permeability factor is detectable in the sera of tumor-bearing mice and cancer patients. Biochem Biophys Acta 1221:211, 1994
28. Dirix LY, Vermeulen PB, Pawinski A, Prove A, Benoy I, De Pooter C, Martin M, Van Oosterom AT: Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients. Br J Cancer 76:238, 1997
29. Dosquet C, Coudert MC, Lepage E, Cabane J, Richard F: Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma. Clin Cancer Res 3(12 Part 1):2451, 1997
30. Leung DW, Cachianes G, Kuang W-J, Goeddel DV, Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306, 1989
31. Sallusto F, Cella M, Danieli C, Lanzavecchia A: Dendritic cells use micropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: Downregulation by cytokines and bacterial products, J Exp Med 182:389, 1995
32. Steinman RM, Lustig DS, Cohn ZA: Identification of a novel cell type in peripheral lymphoid organs of mice. J Exp Med 139:1431, 1974
33. Katz SL, Tamaki K, Sach DH: Epidermal Langerhans cells are derived from cell originating from bone marrow. Nature 282:324, 1979
34. Salomon B, Lores P, Pioche C, Racz P, Jami J, Klatzmann D: Conditional ablation of dendritic cells in transgenic mice. J Immunol 152:537, 1994
35. Pugh CW, MacPherson GG, Steer HW: Characterization of non lymphoid cells derived from rat peripheral lymph. J Exp Med 157:1758, 1983
36. Otsuji M, Kimura Y, Aoe T, Okamoto Y, Saito T: Oxidative stress by tumor-derived macrophages suppresses the expression of CD3 chain of T-cell receptor complex and antigen-specific T-cell responses. Proc Natl Acad Sci USA 93:13119, 1996
37. Barleon B, Sozzani S, Zhou D, Weich HA, Mantovani A, Marme D: Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87:3336, 1996
38. Almeida-Porada G, Porada CD, Shanley JD, Ascensao JL: Altered production of GM-CSF and IL-8 in cytomegalovirus-infected, IL-1-primed umbilical cord endothelial cells. Exp Hematol 25:1278, 1997
39. Lacasse C, Turcotte S, Gingras D, Stankova J, Rola-Pleszczynski M: Platelet-activating factor stimulates interleukin-6 production by human endothelial cells and synergizes with tumor necrosis factor for enhanced production of granulocyte-macrophage colony stimulating factor. Inflammation 21:145, 1997
40. Yamaguchi H, Ishii E, Saito S, Tashiro K, Fujita I, Yoshidomi S, Ohtubo M, Akazawa K, Miyazaki S: Umbilical vein endothelial cells are an important source of c-kit and stem cell factor which regulate the proliferation of haemopoietic progenitor cells. Br J Haematol 94:606, 1996
41. Rafii S, Shapiro F, Pettengell R, Ferns B, Nachman RL, Moore MAS, Asch AS: Human bone marrow microvascular endothelial cells support long-term proliferation and differentiation of myeloid and megakaryocytic progenitors. Blood 86:3353, 1995
42. Davis TA, Black AT, Kidwell WR, Lee KP: Conditioned medium from primary porcine endothelial cells alone promotes the growth of primitive human haematopoietic progenitor cells with a high replating potential: Evidence for a novel early haematopoietic activity. Cytokine 9:263, 1997
43. Magliacco G, Magliacco AR, Adamson JW: The biology of hematopoeitic growth factors: Studies in vitro under serum-deprived conditions. Exp Hematol 18:1049, 1990
44. Southerland HJ, Eaves AC, Eaves CJ: Quantitative assays for human hemopoietic progenitor cells, in Gee AP (ed): Bone Marrow Processing and Purging: A Practical Guide. Boca Raton, FL, CRC, 1991, p 155
45. Van Bekkum DW, van Noord MJ, Maat B, Bicke K: Attempt at identification of hematopoietic stem cells. Blood 42:61, 1973
46. Magli MC, Iscove NN, Odartchenko N: Transient nature of early haematopoietic spleen colonies. Nature 295:527, 1982
47. Jones RJ, Wagner JE, Celano P, Zicha MS, Sharkis SJ: Separation of pluripotent haematopoietic stem cells from spleen colony-forming cells. Nature 347:188, 1990
48. Broxmeyer HE, Cooper S, Li ZH, Lu L, Song H-Y, Kwon BS, Warren RE, Donner DB: Myeloid progenitor cells regulatory effects of vascular endothelial cell growth factor. Int J Hematol 62:203, 1995
49. Nakayama N, Fang I, Elliott G: Natural killer and B-lymphoid potential in CD34+ cells derived from embryonic stem cells differentiated in the presence of vascular endothelial growth factor. Blood 91:2283, 1998
50. Verma IM, Stevenson JK, Scharz EM, Antwerp DV, Miyamoto S: Rel/NF-kB/IkB family: Intimate tales of association and dissociation. Genes Dev 9:2723, 1995
51. Thanos D, Maniatis T; NF-kB - A lesson in family values. Cell 80:529, 1995
52. Carrasco D, Ryseck R-P, Bravo R: Expression of relB transcripts during lymphoid organ development: Specific expression in dendritic antigen-presenting cells. Development 118:1221, 1993
53. Burkly L, Hession C, Ogata L, Relly C, Marconi LA, Olson D, Tizard R, Gate R, Lo D: Expression of RelB is required for development of thymic medulla and dendritic cells. Nature 373:531, 1995
54. Boehmelt G, Madruga J, Dorfler P, Briegel K, Schwarz H, Enrietto PJ, Zenke M: Dendritic cell progenitor is transformed by a conditional v-rel estrogen receptor fusion protein v-RelER. Cell 80:341, 1995
55. Weigh F, Carrasco D, Durham SK, Barton DS, Rizzo CA, Ryseck R-P, Lira SA, Bravo R: Multiorgan inflammation and hematopoi etic abnormalities in mice with a targeted disruption of relB, a member of the NF-kB/Rel family. Cell 80:331, 1995
56. Boothby MR, Mora AL, Scherer DC, Brockman JA, Ballard DW: Perturbation of the T lymphocyte lineage in transgenic mice expressing a constitutive repressor of nuclear factor (NF)-kappaB. J Exp Med 185:1897, 1997
57. Esslinger CW, Wilson A, Sordat B, Beermann F, Jongeneel CV: Abnormal T lymphocyte development induced by targeted overexpression of I-kappa-B-alpha. J Immunol 158:5075, 1997
58. Caamano JH, Rizzo C, Durham SK, Barton DS, Raventos-Suarez C, Snapper CM, Bravo R: Nuclear factor (NF)-kB2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses. J Exp Med 187:185, 1998
59. Franzoso G, Carlson L, Xing L, Poljak L, Shores EW, Brown KD, Leonardi A, Tran T, Boyce BF, Siebenlist U: Requirement for NF-kappa B in osteoclast and B-cell development. Gen Dev 11:3482, 1997
60. Horwitz BH, Scott ML, Cherry SR, Bronson RT, Baltimore D: Failure of lymphopoiesis after adoptive transfer of NF-kappaB-deficient fetal liver cells. Immunity 6:765, 1997
61. Jackson CW: Cholinesterase as a possible marker for early cells of the megakaryocytic series. Blood 42:413, 1973